Mandos Health Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Mandos Health General Information
Description
Developer of a biopharmaceutical drug intended to help patients who are affected with Niemann-Pick Type C1 disease. The company specializes in developing the Adrabetadex drug while collaborating with various partners, clinics, and organizations that are developing drugs for NPC1 diseases, enabling patients to access diagnostic and treatment options for NPC1 disease.
Contact Information
Website
www.mandoshealth.comCorporate Office
- 2101 Corporate Center Drive
- Suite 100
- Thousand Oaks, CA 91320
- United States
Corporate Office
- 2101 Corporate Center Drive
- Suite 100
- Thousand Oaks, CA 91320
- United States
Mandos Health Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Jan-2025 | Completed | Generating Revenue |
Mandos Health Patents
Mandos Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10258641-B2 | Hydroxypropyl beta-cyclodextrin compositions and methods | Active | 10-Jun-2015 | ||
| US-10300086-B2 | Hydroxypropyl beta-cyclodextrin compositions and methods | Active | 10-Jun-2015 | ||
| US-10709730-B2 | Hydroxypropyl beta-cyclodextrin compositions and methods | Active | 10-Jun-2015 | ||
| US-10933083-B2 | Hydroxypropyl beta-cyclodextrin compositions and methods | Active | 10-Jun-2015 | ||
| US-11406657-B2 | Hydroxypropyl beta-cyclodextrin compositions and methods | Active | 10-Jun-2015 | A61K31/724 |
Mandos Health Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Render Capital | Venture Capital | Minority |
Mandos Health Investments (1)
Mandos Health’s most recent deal was a Corporate Asset Purchase with Mallinckrodt Pharmaceuticals (Adrabetadex). The deal was made on 01-Jul-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Mallinckrodt Pharmaceuticals (Adrabetadex) | 01-Jul-2021 | Corporate Asset Purchase | Buildings and Property |
Mandos Health FAQs
-
When was Mandos Health founded?
Mandos Health was founded in 2021.
-
Where is Mandos Health headquartered?
Mandos Health is headquartered in Thousand Oaks, CA.
-
What industry is Mandos Health in?
Mandos Health’s primary industry is Pharmaceuticals.
-
Is Mandos Health a private or public company?
Mandos Health is a Private company.
-
What is Mandos Health’s current revenue?
The current revenue for Mandos Health is .
-
Who are Mandos Health’s investors?
Render Capital has invested in Mandos Health.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process